US President Donald Trump has targeted India yet again. Taking to Truth Social, Trump announced a massive 100% tariff on pharmaceutical products. “Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump wrote in his post.

Trump’s latest announcement on imposing a 100% tariff on pharmaceutical products will severely hit Indian pharma companies. The USA is India’s largest export market for pharmaceutical products. In FY 24, 31% ($8.7 billion) of India’s $27.9 billion pharma exports were exported to the US.

India supplies 45% of generic and 15% of biosimilar drugs consumed in the American market. Trump’s latest announcement will significantly affec

See Full Page